Aytu Biopharma (AYTU) Share-based Compensation Growth (3y) (2017 - 2026)
Aytu Biopharma (AYTU) Share-based Compensation Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 10.06% |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 9.14% |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 0.43% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -8.13% |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | -1.73% |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | -8.04% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Aytu Biopharma | 24.75 Mn | -1.96 Mn | 7.60 Mn | -45.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.25% |
| Dec 31, 2025 | -54.81% |
| Sep 30, 2025 | -54.08% |
| Jun 30, 2025 | -54.88% |
| Dec 31, 2024 | -50.29% |
| Sep 30, 2024 | -51.53% |
| Jun 30, 2024 | -34.08% |
| Dec 31, 2023 | 17.31% |
| Sep 30, 2023 | 26.91% |
| Jun 30, 2023 | 22.62% |
| Mar 31, 2023 | 50.61% |
| Dec 31, 2022 | 167.63% |
| Sep 30, 2022 | 92.50% |
| Jun 30, 2022 | 60.20% |
| Mar 31, 2022 | 49.91% |
| Dec 31, 2021 | 85.01% |
| Sep 30, 2021 | 115.34% |
| Jun 30, 2021 | 113.63% |
| Dec 31, 2020 | 65.04% |
| Sep 30, 2020 | 19.44% |